Natera Operating Margin 2014-2025 | NTRA
Current and historical operating margin for Natera (NTRA) over the last 10 years. The current operating profit margin for Natera as of September 30, 2025 is -14.61%.
| Natera Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $2.12B | $-0.35B | -16.63% |
| 2025-06-30 | $1.97B | $-0.29B | -14.91% |
| 2025-03-31 | $1.83B | $-0.23B | -12.40% |
| 2024-12-31 | $1.70B | $-0.22B | -13.08% |
| 2024-09-30 | $1.53B | $-0.24B | -15.80% |
| 2024-06-30 | $1.36B | $-0.31B | -23.09% |
| 2024-03-31 | $1.21B | $-0.38B | -31.62% |
| 2023-12-31 | $1.08B | $-0.45B | -41.22% |
| 2023-09-30 | $0.99B | $-0.50B | -50.91% |
| 2023-06-30 | $0.93B | $-0.51B | -54.89% |
| 2023-03-31 | $0.87B | $-0.54B | -62.44% |
| 2022-12-31 | $0.82B | $-0.54B | -65.98% |
| 2022-09-30 | $0.78B | $-0.54B | -69.46% |
| 2022-06-30 | $0.72B | $-0.57B | -78.84% |
| 2022-03-31 | $0.67B | $-0.54B | -81.26% |
| 2021-12-31 | $0.63B | $-0.47B | -74.88% |
| 2021-09-30 | $0.56B | $-0.40B | -71.28% |
| 2021-06-30 | $0.50B | $-0.31B | -61.11% |
| 2021-03-31 | $0.45B | $-0.25B | -54.69% |
| 2020-12-31 | $0.39B | $-0.22B | -55.64% |
| 2020-09-30 | $0.36B | $-0.18B | -49.31% |
| 2020-06-30 | $0.34B | $-0.14B | -41.94% |
| 2020-03-31 | $0.33B | $-0.12B | -36.47% |
| 2019-12-31 | $0.30B | $-0.12B | -38.74% |
| 2019-09-30 | $0.29B | $-0.11B | -39.16% |
| 2019-06-30 | $0.27B | $-0.12B | -43.22% |
| 2019-03-31 | $0.26B | $-0.12B | -44.27% |
| 2018-12-31 | $0.26B | $-0.12B | -44.75% |
| 2018-09-30 | $0.24B | $-0.13B | -54.55% |
| 2018-06-30 | $0.23B | $-0.13B | -56.22% |
| 2018-03-31 | $0.22B | $-0.13B | -59.46% |
| 2017-12-31 | $0.21B | $-0.14B | -65.07% |
| 2017-09-30 | $0.20B | $-0.13B | -64.85% |
| 2017-06-30 | $0.20B | $-0.13B | -66.00% |
| 2017-03-31 | $0.20B | $-0.13B | -63.50% |
| 2016-12-31 | $0.21B | $-0.10B | -47.89% |
| 2016-09-30 | $0.22B | $-0.08B | -34.84% |
| 2016-06-30 | $0.21B | $-0.07B | -33.49% |
| 2016-03-31 | $0.21B | $-0.06B | -30.73% |
| 2015-12-31 | $0.19B | $-0.06B | -31.05% |
| 2015-06-30 | $0.14B | $-0.02B | -11.59% |
| 2015-03-31 | $0.13B | $0.00B | -1.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $29.388B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.383B | 28.20 |
| HCA Healthcare (HCA) | United States | $118.848B | 18.81 |
| CVS Health (CVS) | United States | $97.986B | 11.41 |
| Elevance Health (ELV) | United States | $72.888B | 10.95 |
| Cencora (COR) | United States | $70.943B | 22.38 |
| Labcorp Holdings (LH) | United States | $24.032B | 18.32 |
| DiDi Global (DIDIY) | China | $22.638B | 20.91 |
| Viatris (VTRS) | United States | $18.578B | 6.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.296B | 0.00 |
| Solventum (SOLV) | United States | $14.134B | 13.72 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.032B | 27.71 |
| CochLear (CHEOY) | Australia | $11.828B | 0.00 |
| Revvity (RVTY) | United States | $11.462B | 19.94 |
| ICON (ICLR) | Ireland | $10.752B | 10.67 |
| Charles River Laboratories (CRL) | United States | $8.169B | 15.73 |
| Sonic Healthcare (SKHHY) | Australia | $7.784B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.225B | 43.08 |
| Avantor (AVTR) | United States | $6.573B | 10.59 |
| HealthEquity (HQY) | United States | $6.572B | 24.58 |
| PACS (PACS) | United States | $6.136B | 37.31 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.066B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| Sotera Health (SHC) | United States | $4.935B | 23.80 |
| Alignment Healthcare (ALHC) | United States | $4.080B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.098B | 19.34 |
| GeneDx Holdings (WGS) | United States | $2.643B | 46.42 |
| Establishment Labs Holdings (ESTA) | United States | $2.113B | 0.00 |
| Organon (OGN) | United States | $1.999B | 2.11 |
| Surgery Partners (SGRY) | United States | $1.940B | 25.00 |
| Progyny (PGNY) | United States | $1.858B | 36.53 |
| Pediatrix Medical (MD) | United States | $1.844B | 11.01 |
| Ardent Health (ARDT) | United States | $1.339B | 4.37 |
| InnovAge Holding (INNV) | United States | $1.110B | 163.60 |
| CareDx (CDNA) | United States | $1.014B | 16.57 |
| Teladoc Health (TDOC) | United States | $0.831B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.757B | 12.39 |
| Nutex Health (NUTX) | United States | $0.728B | 5.57 |
| Sonida Senior Living (SNDA) | United States | $0.651B | 0.00 |
| Omada Health (OMDA) | United States | $0.634B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.606B | 0.00 |
| Embecta (EMBC) | United States | $0.596B | 3.32 |
| Enhabit (EHAB) | United States | $0.569B | 25.55 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.476B | 8.75 |
| CryoPort (CYRX) | United States | $0.426B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Strata Critical Medical (SRTA) | United States | $0.384B | 0.00 |
| So-Young (SY) | China | $0.373B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.360B | 5.79 |
| Oncology Institute (TOI) | United States | $0.258B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.252B | 0.00 |
| Agilon Health (AGL) | United States | $0.158B | 0.00 |
| LifeMD (LFMD) | United States | $0.140B | 0.00 |
| Beauty Health (SKIN) | United States | $0.135B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.110B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| DocGo (DCGO) | United States | $0.071B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| Pomdoctor - (POM) | China | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.97 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |